For very preterm babies, inhaled nitric oxide in the first week of life seems to help both persistent pulmonary hypertension of the newborn (PPHN) and retinopathy. After the first week, though, inhaled nitric oxide wasn't associated with better outcomes. Inhaled nitric oxide could be reframed as multi-organ protection for very premature babies with PPHN. Read the Nature article

This study compared the costs of an 8-week centre-based pulmonary rehabilitation program to a virtual program. Costs and outcomes were...

Because a drug trial for another drug similar to sotatercept was stopped when it was found to be associated with pericardial effusion...

In chronic thromboembolic pulmonary hypertension (CTEPH), this study found that the cells lining blood vessels (the endothelium) are...

A study looked at 262 very premature babies diagnosed with pulmonary hypertension who were given inhaled nitric oxide. For babies whose...

In the body, variations in several genes were associated with a more than 20-fold increased risk of pulmonary arterial hypertension...

Other studies have shown a relationship between high levels of uric acid and pulmonary arterial hypertension (PAH). This study looked at...

This study looked at the challenges and impacts of non-oral treatments for pulmonary arterial hypertension (PAH), beyond those caused by...

Early use of dual therapy helps newly-diagnosed pulmonary arterial hypertension patients do as well as patients six months past...

Since the 1980s, treatment options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have increased. This study...

A very small (16 patients) phase 2a clinical trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD) looked...

We know methamphetamine use is associated with pulmonary arterial hypertension (PAH), but this population's care needs haven't been...

Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily...

This systemic review summarized the data from six studies that examined whether prostacyclin analogues are safe and useful when used to...

In a small study of 34 pulmonary arterial hypertension (PAH) patients taking triple therapy plus sotatercept, some were able to stop...

A 2024 study looked at the association between socioeconomic disadvantage and pulmonary hypertension. In one New York hospital system,...

Medications for pulmonary arterial hypertension (PAH) are not approved for use in patients with pulmonary hypertension due to...

The ZENITH study examined whether adding sotatercept to people's ongoing therapies reduced the risk of death, lung transplantation, or...

Researchers wanted to know whether an enlarged pulmonary artery could independently predict risk in pulmonary arterial hypertension (in...

Seralutinib is a molecule that blocks inflammation, cell proliferation, and scarring responsible for pulmonary arterial hypertension. The...